Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. 2-(4-amino-2,6-dichloro)phenyliminoimidazolidine
2. 4-aminoclonidine
3. Alo 2145
4. Alo-2145
5. Apraclonidine
6. Iopidine
7. Iopimax
8. P-aminoclonidine
9. Para-aminoclonidine
1. 73218-79-8
2. Apraclonidine Hcl
3. P-aminoclonidine Hydrochloride
4. 2,6-dichloro-n1-(4,5-dihydro-1h-imidazol-2-yl)benzene-1,4-diamine Hydrochloride
5. Iopidine
6. Alo-2145
7. Apraclonidine (hydrochloride)
8. Aplonidine Hydrochloride
9. 2-(4-amino-2,6-dichlorophenylimino)imidazolidine Hydrochloride
10. 3,5-dichloro-4-(2-imidazolidinylidenimino)aniline Hydrochloride
11. Apraclonidine Hydrochloride
12. Al02145
13. 2-((4-amino-2,6-dichlorophenyl)imino)imidazolidine Monohydrochloride
14. Al 02145
15. Chebi:2789
16. D2vw67n38h
17. P-aminoclonidine
18. 73218-79-8 (apraclonidine Hcl)
19. Ncgc00093552-01
20. Al-02145
21. Iopidine (tn)
22. 1,4-benzenediamine, 2,6-dichloro-n(sup 1)-2-imidazolidinylidene-, Monohydrochloride
23. 2,6-dichloro-1-n-(4,5-dihydro-1h-imidazol-2-yl)benzene-1,4-diamine;hydrochloride
24. Nc 14 Hydrochloride
25. 2,6-dichloro-n(1)-(2-imidazolidinylidene)-1,4-benzenediamine Hydrochloride
26. Iopidine Ophthalmic Solution
27. 2,6-dichloro-n(1)-(4,5-dihydro-1h-imidazol-2-yl)-1,4-benzenediamine Monohydrochloride
28. Alo 2145; Aplonidine Hydrochloride; Apraclonidine Hydrochloride; Iopidine; P-aminoclonidine Monohydrochloride
29. Smr000058965
30. Apraclonidine Hydrochloride [usan]
31. Unii-d2vw67n38h
32. Apraclonidine Hydrochloride [usan:usp]
33. 2-(4-amino-2,6-dichloroanilino)-2-imidazoline Hydrochloride
34. 2,6-dichloro-n(sup 1)-(2-imidazolidinylidene)-1,4-benzenediamine Hydrochloride
35. 2,6-dichloro-n(sup 1)-(4,5-dihydro-1h-imidazol-2-yl)-1,4-benzenediamine Monohydrochloride
36. Dsstox_cid_25749
37. Dsstox_rid_81093
38. Dsstox_gsid_45749
39. Schembl41138
40. Mls000028829
41. Mls006010230
42. Chembl1200379
43. Dtxsid6045749
44. Tox21_111207
45. Tox21_500033
46. Hy-12720a
47. Mfcd00135922
48. P-aminoclonidine Hydrochloride, Solid
49. S6583
50. Akos022175501
51. Akos025401362
52. Apraclonidine Hydrochloride (jan/usp)
53. Ccg-221337
54. Ds-7631
55. Lp00033
56. 2-yl)benzene-1,4-diamine Hydrochloride
57. Apraclonidine Hydrochloride [mi]
58. Apraclonidine Hydrochloride [jan]
59. Ncgc00260718-01
60. 1,4-benzenediamine, 2,6-dichloro-n(sup 1)-(4,5-dihydro-1h-imidazol-2-yl)-, Monohydrochloride
61. Ac-12705
62. Ba164186
63. Apraclonidine Hydrochloride [mart.]
64. Apraclonidine Hydrochloride [usp-rs]
65. Apraclonidine Hydrochloride [who-dd]
66. Cas-73218-79-8
67. Db-055734
68. Cs-0031120
69. Eu-0100033
70. Ft-0602878
71. 2,6-dichloro-n1-(4,5-dihydro-1h-imidazol-
72. A 0779
73. C76333
74. D01008
75. Apraclonidine Hydrochloride [orange Book]
76. 218a798
77. A837749
78. A937077
79. Apraclonidine Hydrochloride [usp Impurity]
80. Apraclonidine Hydrochloride [usp Monograph]
81. Sr-01000075247
82. Sr-01000075247-1
83. Q27105817
84. 2-(4-amino-2,6-dichlorophenylimino)imidazolidinehydrochloride
85. 2-[(2,6-dichloro-4-aminophenyl)imino]imidazolidine Hydrochloride
86. Apraclonidine Hydrochloride 100 Microg/ml In Acetonitrile:methanol
87. 2,6-bis(chloranyl)-n1-(4,5-dihydro-1h-imidazol-2-yl)benzene-1,4-diamine Hydrochloride
88. 2-((4-amino-2,6-dichlorophenyl)imino) Imidazolidine Monohydrochloride
1. Iopidine
2. 1,4-benzenediamine, 2,6-dichloro-n'-(4,5-dihydro-1h-imidazol-2-yl)-
Molecular Weight | 281.6 g/mol |
---|---|
Molecular Formula | C9H11Cl3N4 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 2 |
Exact Mass | 280.004929 g/mol |
Monoisotopic Mass | 280.004929 g/mol |
Topological Polar Surface Area | 62.4 Ų |
Heavy Atom Count | 16 |
Formal Charge | 0 |
Complexity | 247 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Apraclonidine hydrochloride |
Drug Label | IOPIDINE Ophthalmic Solution contains apraclonidine hydrochloride, an alpha adrenergic agonist, in a sterile isotonic solution for topical application to the eye. Apraclonidine hydrochloride is a white to off-white powder and is highly soluble in w... |
Active Ingredient | Apraclonidine hydrochloride |
Dosage Form | Solution/drops |
Route | Ophthalmic |
Strength | eq 0.5% base |
Market Status | Prescription |
Company | Akorn |
2 of 2 | |
---|---|
Drug Name | Apraclonidine hydrochloride |
Drug Label | IOPIDINE Ophthalmic Solution contains apraclonidine hydrochloride, an alpha adrenergic agonist, in a sterile isotonic solution for topical application to the eye. Apraclonidine hydrochloride is a white to off-white powder and is highly soluble in w... |
Active Ingredient | Apraclonidine hydrochloride |
Dosage Form | Solution/drops |
Route | Ophthalmic |
Strength | eq 0.5% base |
Market Status | Prescription |
Company | Akorn |
Adrenergic alpha-2 Receptor Agonists
Compounds that bind to and activate ADRENERGIC ALPHA-2 RECEPTORS. (See all compounds classified as Adrenergic alpha-2 Receptor Agonists.)
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Apraclonidine Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Apraclonidine Hydrochloride, including repackagers and relabelers. The FDA regulates Apraclonidine Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Apraclonidine Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Apraclonidine Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Apraclonidine Hydrochloride supplier is an individual or a company that provides Apraclonidine Hydrochloride active pharmaceutical ingredient (API) or Apraclonidine Hydrochloride finished formulations upon request. The Apraclonidine Hydrochloride suppliers may include Apraclonidine Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Apraclonidine Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Apraclonidine Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Apraclonidine Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Apraclonidine Hydrochloride DMFs exist exist since differing nations have different regulations, such as Apraclonidine Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Apraclonidine Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Apraclonidine Hydrochloride USDMF includes data on Apraclonidine Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Apraclonidine Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Apraclonidine Hydrochloride suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Apraclonidine Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Apraclonidine Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Apraclonidine Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Apraclonidine Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Apraclonidine Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Apraclonidine Hydrochloride suppliers with NDC on PharmaCompass.
Apraclonidine Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Apraclonidine Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Apraclonidine Hydrochloride GMP manufacturer or Apraclonidine Hydrochloride GMP API supplier for your needs.
A Apraclonidine Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Apraclonidine Hydrochloride's compliance with Apraclonidine Hydrochloride specifications and serves as a tool for batch-level quality control.
Apraclonidine Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Apraclonidine Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Apraclonidine Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Apraclonidine Hydrochloride EP), Apraclonidine Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Apraclonidine Hydrochloride USP).
LOOKING FOR A SUPPLIER?